Ildiko Gerbatsch Bornemisza
Adult Medicine · San Diego, CANPI 1134258148
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 97 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 16.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,188 and has fallen 96.5% since, to $42 in 2024.
Across 97 payments — averaging $20.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$322
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$217
- AstraZeneca$186
- Amgen$184
- Merck$158
- GSK$136
- plus $785 from 14 others
What the payments were for
- Travel & lodging$60%
- Food & beverage$1,983100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 18 | $322 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 14 | $217 |
| AstraZeneca | 9 | $186 |
| Amgen | 8 | $184 |
| Merck | 9 | $158 |
| GSK | 2 | $136 |
| Boston Scientific | 2 | $129 |
| AbbVie(2 entities) | 6 | $112 |
| Astellas Pharma US Inc | 6 | $103 |
| Sanofi-aventis U.S. LLC | 5 | $84 |
| Dexcom, Inc. | 4 | $83 |
| Amarin Pharma, Inc. | 3 | $54 |
| Novartis | 2 | $45 |
| Medtronic | 1 | $42 |
| Boehringer Ingelheim | 2 | $38 |
| Mannkind Corporation | 2 | $26 |
| Novo Nordisk | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Neotract Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SHINGRIX$113
How this compares
$1,988 in reported general payments places this provider in the 80th percentile of 221 adult medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 100 | $121,196 |
| JanuviaSitagliptin Phosphate | 52 | $64,126 |
| EliquisApixaban | 66 | $46,663 |
| FarxigaDapagliflozin Propanediol | 20 | $20,586 |
| OzempicSemaglutide | 13 | $11,944 |
| TradjentaLinagliptin | 11 | $10,139 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 45 | $5,509 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 18 | $5,226 |
| Atorvastatin Calcium | 378 | $3,959 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 84 | $2,848 |
| Wixela InhubFluticasone Propion/Salmeterol | 17 | $2,402 |
| Gabapentin | 181 | $2,248 |
| Baclofen | 134 | $2,215 |
| Levothyroxine Sodium | 193 | $2,184 |
| Diclofenac Sodium | 113 | $1,960 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta | $38 | $131,335111 claims |
| MerckJanuvia | $158 | $64,12652 claims |
| AstraZenecaFarxiga | $186 | $20,58620 claims |
| Novo NordiskOzempic | $18 | $11,94413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 221 adult medicine providers in California.
Other adult medicine in San Diego
- Yasuko KidokoroSan Diego$1K
- Susan HutchinsonLaguna Hills$1M
- Natalia GuzmanLos Angeles$583K
- Richard FauselRancho Mirage$30K
- Benedicto EstoestaValley Springs$22K
- Antoine DipsiaW. Sacramento$21K
- Patrick WelchArroyo Grande$20K
- Craig BobsonManteca$19K
- Tin WongLos Angeles$18K
- Sofia VaismanWoodland Hills$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.